Seminar Series
The Department of Pharmacological Sciences hosts a biweekly research Seminar Series by invited speakers on the topics of drug design and discovery, and molecular and systems pharmacology, held on Thursdays at 11 am in the Hess Center for Science and Medicine building. If you’re interested in joining the mailing list for this Seminar Series in the future, please contact DPS@mssm.edu.
2023 |
|
Date |
Details |
December 8 |
“Learning about Prostate Cancer by Studying Mouse Models” Cory Abate-Shen, Ph.D. |
October 19 |
“Cancer Drug Discovery using Fragment-Based Methods” Stephen Fesik, Ph.D. |
October 12 |
“DNA-Encoded Library Technology: A Valuable Tool for Drug Discovery and Biomedical Research” Matthew A. Clark, Ph.D. |
June 22 |
“Intrinsically Disordered Domains in the Phosphoregulation of Transporter Activity” Thomas Tomasiak, Ph.D. |
June 8 |
“Towards Translational Clinical Proteomics” Jun Qin, Ph.D |
May 11 |
“The Role of Innate-like T Cells in Protecting Meningeal Integrity and Cognitive Function” Qi Yang, M.D. Rutgers University |
April 27 |
“Identifying Inhibitors of Antibiotic Resistance Enzymes Using DNA-encoded Chemical Libraries” Tim Pazkill, Ph.D. |
April 13 |
“Mechanisms and Roles of Fast Dopamine Signaling” Pascal Kaeser, M.D. Hosted by Jinye Dai, Ph.D. |
March 30 |
“Transforming Academic Drug Discovery: From Concept to an On Demand, Non-hormonal Male Contraceptive” Peter T. Meinke, Ph.D. |
March 16 |
“Epigenetic Control of Regulatory T Cell Suppressive Capacity” |
January 19 |
“Architecture of Erythrocyte Ankyrin-1 Complexes” |
January 12 |
" Regulation of GPCR Signaling by Ubiquitination" Sudha Shenoy, Ph.D. |
Date |
Details |
November 3 |
“Targeting Dysfunctions in Protein-Protein Interaction Networks" |
October 20 |
“Targeting New Signal Pathways for Prevention and Treatment of Cancer and Diabetes” |
September 22 |
“Exploiting a Unique Post-Translational Modification to Enhance |
June 17 |
“A Unifying Mechanism for Drug-Induced Formation of New Oligodendrocytes” |
June 8 |
“Targeting Ion Channels for Drug Discovery - Cardiac Arrhythmia & COVID-19” |
May 11 |
“Mechanisms of Enhancer Assembly: What can we Learn to Develop Pharmacological Interventions for Cancers” |
May 5 |
“Mechanism of Pathogenic Endothelial and Podocyte Cross-Talk” |
April 21 |
“Molecular Simulations in the Times of COVID-19 and the Opioid Crisis” |
April 7 |
“Molecular Mechanisms of Epigenetic Regulation” |
February 24 |
“Translational Pharmacogenomics Advances in the Mount Sinai Health System” |
February 10 |
“Antibodies Against Emerging Infectious Disease” |
January 13 |
"Computational Microscopy of SARS-CoV-2" |
Date |
Details |
November 11 |
"Interindividual Variability in Drug Metabolism and Bioactivation: Implications for Ethnically Diverse Populations" |
October 28 |
"Nanobodies as Tools to Interrogate Transmembrane Receptor Signaling" |
September 16 |
"Topoisomerase V: The Forgotten Topoisomerase and Other Stories" |
September 2 |
"Multidisciplinary Journey Integrating Basic Sciences and Translational Drug Discovery to validate a First-in-class Target and Pharmacotherapy for Addictive Disorders" |
August 5 |
“Impact of Chronic Pain on Mesolimbic Reward Circuitry” |
June 10 |
“N-tertaining a New Signaling Paradigm for Protease Regulated Cardiomyocyte beta1-Adrenergic Receptors” |
May 27 |
“Dissecting Molecular Machinery for Neurotransmission and Neuromodulation” |
April 29 |
“Insights into GPX4 and ferroptosis through analysis of a patient variant” |
April 15 |
“BRD4 in Transcription Programming and Cancer Therapy” |
April 8 |
“Engineering the Premetastatic Niche” |
March 4 |
“Structural Mechanisms of AMPA Receptor Regulation and Gating’ |
February 11 |
"Mechanics of an Nramp Family Transition Metal Transporter” |
January 14 |
"Designing Bitopic or Bivalent Molecules for the Treatment of Substance Use Disorders" |
Date |
Details |
December 17 |
“Circuit and Synaptic Mechanisms Underlying Vulnerability for Drug Abuse” |
October 29 |
"Neurobiological pathways lead the development of novel treatments for opioid addiction" |
October 1 |
“Selective inhibition and degradation of oncogenic RAS mutants, with a touch of COVID" |
September 17 |
“Early life stress and susceptibility to schizophrenia and depression” |
February 6 |
“Integrating 3D structure into Systems Biology” |
January 23 |
“Synthetic Targeting of Protein-Protein Interactions in Cancer” |
Date |
Details |
December 5 |
"Complex Dynamics of Glutamate Transporters" |
November 7 |
"The Sodium/Iodide Symporter (NIS): From Patient to Molecule and Back" |
October 17 |
"RNA Methylation in Gene Regulation and Cancer" |
October 3 |
"Arginine Methylation -Substrates, Effectors & Crosstalk" |
September 19 |
"Designing the Next Generation of Computational Microscopes with Statistical Mechanics and Artificial Intelligence" |
June 20 |
“Redox-inactivation of Cardiomyocyte Beta1-adrenergic receptors: Carvedilol to the Rescue" |
June 6 |
"Biological Photocontrol: From Optogenetic Engineering to Phototherapeutics" |
May 16 |
“Acetylcholine Signaling and Stress-Induced Behaviors” |
May 2 |
"Cryo-EM and Integrative Structural Biology" |
April 18 |
“Exploring novel roles of Disheveled in cancer biology and transcription regulation” |
April 4 |
“Molecular Mechanisms of TRPV Channels Gating by Endogenous and Exogenous Modulators” |
March 19 |
“Network analysis and visualization with STRING and Cytoscape” |
March 7 |
“Endosomal pH as a Therapeutic Target in Neurodegenerative Disease” |
February 21 |
“GPCR Signaling in Osteoblasts by Parathyroid Hormone and its Analogs” |
February 7 |
“Regulation of Notch Signaling by O-Glycans” |
January 17 |
”Dendritic Integration and Fragile X Syndrome” |